Last reviewed · How we verify
Botulinum toxin injected to bladder body
At a glance
| Generic name | Botulinum toxin injected to bladder body |
|---|---|
| Also known as | Botulinum toxin, Onabotulinumtoxin, Botox |
| Sponsor | Mr HD Flood |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A (PHASE4)
- Comparative Study Suburothelial and Trigonal Botulinum Toxin A Injection in Treatment of Interstitial Cystitis (PHASE2)
- Botulinum Toxin in the Treatment of Idiopathic Detrusor Overactivity (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Botulinum toxin injected to bladder body CI brief — competitive landscape report
- Botulinum toxin injected to bladder body updates RSS · CI watch RSS
- Mr HD Flood portfolio CI